Literature DB >> 17688387

Drug-induced photoallergic and phototoxic reactions.

Kevin R Stein1, Noah S Scheinfeld.   

Abstract

Drug-induced photosensitivity involves reactions to medication triggered by exposure of the skin to ultraviolet light. Medications that trigger reactions can be topical or oral. Following interaction of ultraviolet radiation with a chemical present in sufficient amounts in the skin, one of the several reactions may occur in susceptible patients, most commonly photoallergy or phototoxicity. These reactions can be diagnosed separately based on pathogenesis, clinical characteristics and histopathology. Phototoxic disorders have a higher incidence than photoallergic disorders. The action spectra for most photoallergens and phototoxins lie in the ultraviolet A range. Subtypes of drug-induced photosensitivity include dyschromia, pseudoporphyria, photo onycholysis, and lichenoid and telangiectatic reactions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17688387     DOI: 10.1517/14740338.6.4.431

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  17 in total

1.  Inhalable powder formulation of pirfenidone with reduced phototoxic risk for treatment of pulmonary fibrosis.

Authors:  Satomi Onoue; Yoshiki Seto; Masashi Kato; Yosuke Aoki; Yoshiki Kojo; Shizuo Yamada
Journal:  Pharm Res       Date:  2013-02-21       Impact factor: 4.200

2.  Phototoxic Rash during Therapy with Pramipexole in a Patient with Restless Legs Syndrome.

Authors:  Husein H Elahmed
Journal:  Sultan Qaboos Univ Med J       Date:  2013-02-27

3.  [Phototoxic and photoallergic reactions].

Authors:  N J Neumann; S Schauder
Journal:  Hautarzt       Date:  2013-05       Impact factor: 0.751

4.  High-throughput screening system for identifying phototoxic potential of drug candidates based on derivatives of reactive oxygen metabolites.

Authors:  Satomi Onoue; Masanori Ochi; Graham Gandy; Yoshiki Seto; Naoko Igarashi; Yukinori Yamauchi; Shizuo Yamada
Journal:  Pharm Res       Date:  2010-04-27       Impact factor: 4.200

Review 5.  Eczematous Drug Eruptions.

Authors:  Amy E Blum; Susan Burgin
Journal:  Am J Clin Dermatol       Date:  2021-02-15       Impact factor: 7.403

6.  New agents for prevention of ultraviolet-induced nonmelanoma skin cancer.

Authors:  William L Camp; Jennifer W Turnham; Mohammad Athar; Craig A Elmets
Journal:  Semin Cutan Med Surg       Date:  2011-03

7.  Exposure to phototoxic NSAIDs and quinolones is associated with an increased risk of melanoma.

Authors:  Satu J Siiskonen; Els R Koomen; Loes E Visser; Ron M C Herings; Henk-Jan Guchelaar; Bruno H Ch Stricker; Tamar E C Nijsten
Journal:  Eur J Clin Pharmacol       Date:  2013-03-08       Impact factor: 2.953

8.  Voriconazole-induced phototoxicity masquerading as chronic graft-versus-host disease of the skin in allogeneic hematopoietic cell transplant recipients.

Authors:  Asha R Patel; Maria L Turner; Kristin Baird; Juan Gea-Banacloche; Sandra Mitchell; Steven Z Pavletic; Barbara Wise; Edward W Cowen
Journal:  Biol Blood Marrow Transplant       Date:  2009-03       Impact factor: 5.742

9.  Risk of Nonmelanoma Skin Cancer in Association With Use of Hydrochlorothiazide-Containing Products in the United States.

Authors:  Efe Eworuke; Nicole Haug; Marie Bradley; Austin Cosgrove; Tancy Zhang; Elizabeth C Dee; Sruthi Adimadhyam; Andrew Petrone; Hana Lee; Tiffany Woodworth; Sengwee Toh
Journal:  JNCI Cancer Spectr       Date:  2021-02-04

Review 10.  Photosensitizing Medications and Skin Cancer: A Comprehensive Review.

Authors:  Elisabeth A George; Navya Baranwal; Jae H Kang; Abrar A Qureshi; Aaron M Drucker; Eunyoung Cho
Journal:  Cancers (Basel)       Date:  2021-05-12       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.